Susquehanna International Group, LLP Dyne Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 25,521 shares of DYN stock, worth $887,109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,521
Previous 440,534
94.21%
Holding current value
$887,109
Previous $12.5 Million
92.8%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding DYN
# of Institutions
201Shares Held
106MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$279 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$273 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$257 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$222 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$210 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.8B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...